NetraMark Holdings ( ($TSE:AIAI) ) just unveiled an update. NetraMark has announced the launch of NetraAI 2.0, an advanced platform aimed at ...

Targeted Variable Analysis: Identify hard-to-detect combinations ... Delivering Key Benefits for Your Trials Enhanced Efficacy: Optimize key clinical endpoints with high effect-size models for ...

Clinical trial complexity has significantly increased in the past decade. How can the industry adapt and innovate to remain ...

Adding probiotics to antipsychotic treatment is associated with a significant decrease in schizophrenia symptoms, a new ...

Rezolute , Inc. (NASDAQ:RZLT), a clinical-stage biopharmaceutical company, is making significant strides in the development of its lead drug candidate, ersodetug, for the treatment of congenital ...

At the Envision Summit 2025 in San Juan, Puerto Rico, Deepak Sambhara, MD, gave insight into the 96-week post hoc fluid ...

Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...

The Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, has been involved with three papers published this week in The Lancet and ...

By transforming clinical trial data into actionable insights ... by assessing stability and variability across patient populations. Targeted Variable Analysis: Identify hard-to-detect combinations of ...

Targeted Variable Analysis: Identify hard-to-detect combinations of key ... Delivering Key Benefits for Your Trials Enhanced Efficacy: Optimize key clinical endpoints with high effect-size models for ...